A detailed history of Spider Rock Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 26,917 shares of MRNA stock, worth $991,891. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,917
Previous 1,745 1442.52%
Holding current value
$991,891
Previous $207,000 768.6%
% of portfolio
0.03%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$63.64 - $125.14 $1.6 Million - $3.15 Million
25,172 Added 1442.52%
26,917 $1.8 Million
Q2 2024

Aug 12, 2024

SELL
$101.21 - $166.61 $405,042 - $666,773
-4,002 Reduced 69.64%
1,745 $207,000
Q1 2024

Apr 30, 2024

BUY
$85.37 - $115.44 $490,621 - $663,433
5,747 New
5,747 $612,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.